Presented by

Julia Coombes, MHRA ; Liam Deevey, BMS ; Elena Cucu, AbbVie

About this talk

This session explore the recent issues surrounding shortages of medicines in the UK. It focus on the role of the QPPV and what is expected of them in these situations. Discussions include strategies for addressing potential shortages, as well as the importance of communication and collaboration between stakeholders. Overall, this session provides valuable insights and practical solutions shared by industry and regulators as well as clarify the expectations from the MHRA, including the role of the QPPV in this matter.
Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (53)
Subscribers (530)
The Drug Information Association (DIA) is a global and neutral association that mobilizes the life science community (regulators, industry, healthcare professionals, patients, payers, and students) to identify and tackle the most complex health challenges. DIA brings all these stakeholders together to find and discuss solutions, build a more robust and innovative healthcare ecosystem and, ultimately, improve patient outcomes worldwide. DIA executes its mission by fostering timely and critical conversations and networking sessions across many platforms, including conferences, workshops, DIA-led research projects, structured training, eLearning courses, digital content platforms, and publications, without corporate funding.